Figure 4.
Co-occurrence of KRAS mutations with somatic alterations in ALK, EGFR, and STK11 genes in patients with lung adenocarcinoma. Shown is a submatrix plot with detected gene alterations denoted by a colored bar (blue). Patients without any of these specific genomic alterations are classified as “wild type” (gray).